Global export opportunity Indoco exports to regulated and emerging markets including the USA and EU, with a branded formulation presence in South East Asia, Africa, Latin America and CIS. Sales teams can target international distributors, contract manufacturing partnerships, and regulatory-driven channels to expand footprint in these regions, leveraging EU GMP certification and USFDA IAS capabilities.

EU GMP momentum Recent EU GMP certifications for oral solid dosage plants and sterile facilities enhance credibility with European buyers and global contract manufacturers. This strengthens potential tender opportunities, OEM/ODM partnerships, and higher-value export deals for OSDS, sterile injectables, and specialty dosage forms.

Strong product portfolio A broad brand portfolio across therapeutics such as GI, respiratory, anti-infectives, vitamins, ophthalmics, antifungals, and cardiovascular segments, plus a track record of top brands and formulations, positions Indoco to cross-sell to existing distributors and pursue multi-therapy hospital and retail contracts in new markets.

R&D manufacturing edge With an integrated R&D engine focused on non-infringing APIs, advanced dosage forms, and long-acting injectables, Indoco can offer value-added development collaborations, early access to innovations, and tailored formulations for generic and branded opportunities targeting regulatory windows and market needs.

Analytical partnerships IAS division operates USFDA-approved analytical research services at Navi Mumbai, creating potential for analytics outsourcing, method development, stability studies, and regulatory submissions support for partner companies seeking cost-efficient, globally compliant testing capabilities.